William P. Vaughan - Concepedia

Author

William P. Vaughan

Also Known As

Robert Bailey, Tien Tran, Vaughan, Vaughan, William P., W P Vaughan, W VAUGHAN, W Vaughan, W. P. Vaughan, W. Vaughan, W.P. Vaughan

145

Publications

4.5K

Citations

H-Index

105

Concepts

All Affiliations

University of Nebraska Medical Center University of Alabama at Birmingham Palmetto Hematology Oncology Nebraska Medical Center Johns Hopkins University

About

William P. Vaughan is an author at University of Nebraska Medical Center specializing in medicine, oncology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	30	2K
2	Health Sciences	8	8	502
3	Allergy	1	1	203
4	Biochemistry	1	1	40
5	Biomedical Engineering	1	1	77

William P. Vaughan

Publications

4.1K

Citations

H-Index

Page 1

	Year	Citations
High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America. Karen H. Antman, Philip A. Rowlings, William P. Vaughan, Journal of Clinical Oncology	1997	327
Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients Richard Robbins, J Linder, Marlin G. Stahl, The American Journal of Medicine TransplantationMarrow TransplantationBone Marrow FailureHematologySepsis	1989	237
Intravenous versus oral busulfan as part of a busulfan/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: Decreased incidence of hepatic venoocclusive disease (HVOD), HVOD-related mortality, and overall 100-day mortality Ashwin Kashyap, John R. Wingard, Pablo J. Cagnoni, Biology of Blood and Marrow Transplantation	2002	225
Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin's disease. Sundar Jagannath, Jamés O. Armitage, K. A. Dicke, Journal of Clinical Oncology Prognostic FactorsTransplantation MedicineImmunologyCell Replacement TherapyPharmacotherapy	1989	210
Fractional Processing of Sequential Bronchoalveolar Lavage to Separate Bronchial and Alveolar Samples Stephen I. Rennard, Mo Ghafouri, Austin B. Thompson, American Review of Respiratory Disease AsthmaInflammatory Lung DiseaseLung InflammationPulmonary Alveolar ProteinosisBronchoalveolar Lavage	1990	203
Conventional Adjuvant Chemotherapy with or without High-Dose Chemotherapy and Autologous Stem-Cell Transplantation in High-Risk Breast Cancer Martin S. Tallman, Robert P. Gray, Nicholas J. Robert, New England Journal of Medicine	2003	191
Colonization and Infection with Trichosporon Species in the Immunosuppressed Host Helen M. Haupt, William G. Merz, W. E. Beschomer, The Journal of Infectious Diseases Parasitic DiseaseTyphoid FeverParasitic ProtozoaPathogenesisImmunology	1983	180
Acute safety and pharmacokinetics of intravenous busulfan when used with oral busulfan and cyclophosphamide as pretransplantation conditioning therapy: A phase I study Börje S. Andersson, Timothy Madden, Hai T. Tran, Biology of Blood and Marrow Transplantation	2000	152
Long chemotherapy-free remissions after single-cycle timed-sequential chemotherapy for acute myelocytic leukemia William P. Vaughan, Judith E. Karp, Philip J. Burke Cancer	1980	116
A Multicenter Study of Platelet Recovery and Utilization in Patients After Myeloablative Therapy and Hematopoietic Stem Cell Transplantation Steven H. Bernstein, Auayporn Nademanee, Julie M. Vose, Blood	1998	115

Page 1